Vertex to seek approval of IgAN drug after Phase III success
Vertex Pharmaceuticals will head to US regulators after its immunoglobulin A nephropathy (IgAN) drug povetacicept was successful in a Phase …
Post
-
-
Building for decades: Dubai’s long game in life sciences
Editor's note: This feature was reported in part prior to the escalation of hostilities in the Gulf, when Iran launched …
-
Pfizer’s trispecific heads to Phase III on mid-stage AD success
American pharmaceutical giant Pfizer is planning to take its trispecific antibody, tilrekimig, to Phase III in atopic dermatitis (AD) as …
-
Veru enrols first patient in Phase IIb trial of enobosarm and semaglutide combo
Veru has announced the first patient enrolment in its Phase IIb PLATEAU study assessing the combination of enobosarm, an oral …
-
AbbVie reports topline data from Phase I ABBV-295 trial
AbbVie has reported positive top line data from the multiple ascending dose (MAD) section of its Phase I trial of …
-
Roche’s oral SERD fails in Phase III breast cancer trial
Roche’s oral selective oestrogen receptor degrader (SERD) has failed to meet its primary endpoint in a Phase III breast cancer …
-
Analysts tout market potential of Xenon’s epilepsy drug on Phase III win
Analysts have touted the market potential of Xenon Pharmaceuticals’ novel epilepsy drug, azetukalner, following a positive late-stage readout in patients …
-
Study explores links between gestational diabetes, prenatal depression and childhood obesity
In the US, the burden of childhood obesity has posed a formidable public health problem. Obesity in early life predisposes …
-
Long-term aspirin use is associated with lower ovarian cancer risk
Ovarian cancer is a leading cause of gynaecological cancer mortality worldwide. Early symptoms of ovarian cancer can include decreased appetite, …
-
Opening clinical trials to pregnant women
Pregnant and breastfeeding women have historically been excluded from medical research, resulting in substantial gaps in evidence on the safety …
-
Vinay Prasad to leave the FDA again
Vinay Prasad is once again set to depart from his role at the US Food and Drug Administration (FDA), after …
-
Dyne commences Phase III HARMONIA trial for DM1 therapy
Dyne Therapeutics has initiated the Phase III HARMONIA trial to evaluate the efficacy, safety, and tolerability of zeleciment basivarsen (z-basivarsen, …
-
Aisa Pharma reports positive results for AISA-021
Aisa Pharma has reported positive results from its Phase II RECONNOITER trial of AISA-021 (cilnidipine), a once-daily calcium channel blocker, …
-
Roche and Zealand’s Phase II obesity trial divides analyst opinion
Roche and Zealand Pharma’s co-developed amylin analogue, petrelintide, has met its primary endpoint in a Phase II trial, but the …
-
Women first: the Gulf’s new healthcare blueprint
Nabta Health, a Dubai-based women's health company, is up for a prestigious MedTech award, but its founder Sophie Smith has …
